EMEA-002298-PIP01-17-M01

Key facts

Active substance
Evinacumab
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0105/2020
PIP number
EMEA-002298-PIP01-17-M01
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Intravenous use
Contact for public enquiries
Regeneron Ireland U.C.

Tel.  +1 9148475385
E-mail: clinicaltrials@regeneron.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating